1 GLP-1 drugs efficacy in preventing the onset of diabetes in patients with prediabetes is also noteworthya study suggests that it can lower the risk of developing diabetes by a whopping 72%
The product is only FDA u003cemu003eregistered u003c/emu003eas a wellness device, which does not mean approval for safety or proven effectiveness
Ozempic, Wegovy, and Mounjaro are no longer news
GLP-1 receptor agonists are medications that mimic a natural hormone in the body (glucagon-like peptide-1) to help regulate blood sugar and control appetite
December 31, 2025
Studies in mice and humans showed that GLP-1 liraglutide acts directly and indirectly in LDL and VLDL catabolism, increases lipoprotein lipase gene expression responsible for TAG hydrolysis, and reduces apolipoprotein B48, diacylglycerol O -acyltransferase 1, and microsomal transfer protein gene expression, all of which are involved in chylomicron synthesis [77, 78]